Status | 已發表Published |
使用基础胰岛素类似物治疗2型糖尿病患者低血糖发生率研究:基于中国4家三级甲等医院的真实数据 | |
Alternative Title | Rate of hypoglycemic events in type 2 diabetes patients using basal insulin analogues: a real-world analysis of four grade Ш class A hospitals in China |
Ung, O. L. C.; Li, L.; Hu, H. | |
2019-06-01 | |
Source Publication | 中国糖尿病杂志 |
ISSN | 1006-6187 |
Pages | 331-336 |
Abstract | Objectives To analyze the rate of hypoglycemic events in type 2 diabetes patients using basal insulin analogues in China. Methods Retrospective electronic health record data from 4 Grade Ⅲ Class A hospitals in China from January 2012 to May 2017 was analyzed. Including criteria were patients of type 2 diabetes treated with basal insulin analogues,including insulin glargine,insulin detemir and recombinant insulin glargine. Results 4552 patients were included. 912(18. 8%)patients experienced hypoglycemia. The overall incidence of hypoglycemia was 107. 99 events/100 patient‐year,of which,non‐severe hypoglycemia accounted for 96. 28 events/100 patient‐year and severe hypoglycemia 11. 71 events/100 patientyear. The rate of hypoglycaemia was relatively low in patients treated with insulin detemir. Conclusion Hypoglycemic events in patients treated with basal insulin analogues in China |
Keyword | Diabetes mellitus type 2 Hypoglycemia Basal insulin analogue Insulin glargine |
URL | View the original |
Language | 其他語言Others |
The Source to Article | PB_Publication |
PUB ID | 43949 |
Document Type | Journal article |
Collection | Institute of Chinese Medical Sciences |
Corresponding Author | Hu, H. |
Recommended Citation GB/T 7714 | Ung, O. L. C.,Li, L.,Hu, H.. 使用基础胰岛素类似物治疗2型糖尿病患者低血糖发生率研究:基于中国4家三级甲等医院的真实数据[J]. 中国糖尿病杂志, 2019, 331-336. |
APA | Ung, O. L. C.., Li, L.., & Hu, H. (2019). 使用基础胰岛素类似物治疗2型糖尿病患者低血糖发生率研究:基于中国4家三级甲等医院的真实数据. 中国糖尿病杂志, 331-336. |
MLA | Ung, O. L. C.,et al."使用基础胰岛素类似物治疗2型糖尿病患者低血糖发生率研究:基于中国4家三级甲等医院的真实数据".中国糖尿病杂志 (2019):331-336. |
Files in This Item: | There are no files associated with this item. |
Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.
Edit Comment